Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 108 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy				Phase IV				AVO108943 NCT00470834
	Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia				Phase III, Phase II				001-0015-211 NCT00127387
	Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer				Phase III				05-043 NCT00116142
	Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer				Phase III				05-007 NCT00142506
	Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma				Phase III				553 NCT00132301
	Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial				Phase III				05-8-4 NCT00243646
	Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer				Phase III				RTOG-0521 NCT00288080
	Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy				Phase III				RTOG-0518 0518, NCT00329797
	Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer				Phase III				ROLL-GUP-0205-1 UCLA-0507059-01, NCT00336934
	Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer				Phase III				CALGB-90203 NCT00430183


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute